Dr. McDermott on the Promise of Pembrolizumab in Non-Clear Cell RCC OncLive 1:10 5 years ago 89 Далее Скачать
Dr. McDermott on Single-Agent Pembrolizumab in Advanced RCC OncLive 1:58 5 years ago 262 Далее Скачать
Promising results of cabozantinib plus nivolumab in non-clear cell RCC VJOncology 1:20 1 year ago 204 Далее Скачать
Dr. McDermott on Single-Agent Versus Combination Immunotherapy in RCC OncLive 1:15 5 years ago 109 Далее Скачать
Using Combination Therapy as Treatment of Non-Clear Cell RCC Targeted Oncology 1:49 4 years ago 104 Далее Скачать
Combining lenvatinib & pembrolizumab for non-clear cell RCC: KEYNOTE-B61 study rationale VJOncology 0:59 1 year ago 216 Далее Скачать
Dr. McDermott on PD-L1 Expression in Non-Clear Cell Renal Cell Cancer Targeted Oncology 0:51 10 years ago 68 Далее Скачать
Dr. McDermott on Immunotherapy as a Standard of Care in RCC OncLive 0:54 6 years ago 129 Далее Скачать
Dr. McDermott on Toxicities of Immunotherapy Combinations in RCC OncLive 1:16 4 years ago 78 Далее Скачать
KEYNOTE-427 cohort B: first-line pembrolizumab monotherapy for advanced non-clear cell renal cel... ecancer 5:04 5 years ago 86 Далее Скачать
McDermott: Immunotherapy Agents in Renal Cell Carcinoma Cancer Therapy Advisor 1:08 9 years ago 55 Далее Скачать
Dr. Burtness on Promise of Frontline Pembrolizumab in Metastatic HNSCC OncLive 1:52 5 years ago 177 Далее Скачать
Promising results for axitinib and pembrolizumab in advanced renal cell cancer VJOncology 3:30 6 years ago 2 136 Далее Скачать
